title: Desensitization to lenalidomide in a patient with relapsed multiple myeloma.
authors.affiliation: Department of Pharmacy, Princess Margaret Hospital, Toronto, Ontario, Canada.
authors.forename: Jack T
authors.initials: JT
authors.lastname: Seki
authors.forename: Sabiha
authors.initials: S
authors.lastname: Banglawala
authors.forename: Emily M
authors.initials: EM
authors.lastname: Lentz
authors.forename: Donna E
authors.initials: DE
authors.lastname: Reece
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012008:Recurrence; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide